<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17039" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Incomplete Miscarriage</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Redinger</surname>
            <given-names>Ashley</given-names>
          </name>
          <aff>Michigan State University, Garden City Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nguyen</surname>
            <given-names>Hao</given-names>
          </name>
          <aff>Michigan State University/Garden City Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashley Redinger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hao Nguyen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17039.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Incomplete pregnancy loss, also known as incomplete miscarriage or incomplete abortion, is the partial loss of products of conception within the first 20 weeks of gestation. Incomplete miscarriage presents with moderate to severe vaginal bleeding, sometimes with the noticeable passage of tissue, that is typically associated with lower abdominal and pelvic pain. Diagnosis is made primarily through visualizing pregnancy tissue in the cervical os during a speculum examination. An ultrasound finding of heterogeneous or echogenic tissue within the endometrial canal in a patient with the characteristic clinical features of a miscarriage or the expulsion of products of conception that is less than generally expected for a given gestational age also supports a diagnosis of incomplete pregnancy loss. Management options include expectant, medical, and surgical treatments, although expectant management alone is often highly successful. Proper diagnosis and treatment with close obstetric follow-up and patient education are essential to prevent serious complications.&#x000a0;This activity for healthcare professionals is designed to enhance the learner's competence when managing incomplete pregnancy loss, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved care coordination, leading to better patient outcomes and reduced maternal morbidity.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical features of incomplete pregnancy loss and characteristic findings on imaging studies.</p></list-item><list-item><p>Assess patients presenting with first-trimester bleeding and cramping.</p></list-item><list-item><p>Differentiate incomplete miscarriage from other etiologies of first-trimester bleeding.</p></list-item><list-item><p>Select the appropriate management approaches for incomplete pregnancy loss.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17039&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17039">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17039.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The gestational ages and classifications professional organizations use to categorize miscarriages differ in terminology. Currently, the gestational age divisions for various pregnancy loss terms, particularly internationally, are not well defined. Traditionally in the US, however, a "miscarriage," sometimes termed a "spontaneous abortion," is defined as a spontaneous loss of a nonviable intrauterine pregnancy within the first 20 weeks of gestation; a fetal demise after 20 weeks of gestation is generally termed a "stillbirth" or "intrauterine fetal demise."<xref ref-type="bibr" rid="article-17039.r1">[1]</xref><xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;An&#x000a0;"early miscarriage" or "early pregnancy loss" commonly refers to a loss&#x000a0;occurring before 10 to 13 weeks of gestation.<xref ref-type="bibr" rid="article-17039.r3">[3]</xref><xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;The term "incomplete miscarriage," also known as an "incomplete pregnancy loss" or "incomplete spontaneous abortion," is generally defined as&#x000a0;a specific subtype of miscarriage in which the products of conception (POC) have not been completely expelled from the uterus.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref><xref ref-type="bibr" rid="article-17039.r3">[3]</xref></p>
        <p>The term "inevitable miscarriage" was sometimes used by clinicians to characterize a miscarriage in which the cervical os is open, and symptoms of vaginal bleeding and pelvic cramping are present; however, no POC have been expelled. In an incomplete pregnancy loss, though the cervical os is also open and vaginal bleeding and cramping are also present, there is partial, but not yet complete, expulsion of the POC. Differentiating these two traditional subtypes can be difficult, and they have no significant prognostic or management differences. For this reason, many clinicians prefer not to use the term "inevitable miscarriage."<xref ref-type="bibr" rid="article-17039.r5">[5]</xref><xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
        <p>The overall incidence of spontaneous pregnancy loss is 10% to 15% in clinically recognized pregnancies. The incidence of incomplete pregnancy loss has not been well studied; however, the incidence of incomplete second-trimester abortions following surgical and medical modalities is 1% and 8%, respectively.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref><xref ref-type="bibr" rid="article-17039.r6">[6]</xref>&#x000a0;The etiology of any spontaneous pregnancy loss is often&#x000a0;unknown, but up to 50% of cases are thought to be due to fetal chromosomal abnormalities.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;</p>
        <p>An incomplete miscarriage is typically diagnosed with a history, physical exam, and pelvic ultrasound; at early gestational ages, a &#x003b2;-human chorionic gonadotropin (&#x003b2;-hCG) level may also be indicated to make a proper diagnosis. Patients with an incomplete miscarriage typically present with vaginal bleeding, lower abdominopelvic pain or cramping, and an open cervical os before 20 weeks of gestation. Incomplete miscarriage should be differentiated from a threatened miscarriage, which refers to a pregnancy complicated by vaginal bleeding with a closed cervical os that is found to be viable on ultrasound, and a complete miscarriage in which all the POC have been expelled from the uterus, and the cervix has closed again. Other differential diagnoses should also be excluded (eg, ectopic pregnancy, molar pregnancy, and nonobstetric causes of bleeding).<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;</p>
        <p>Management options include expectant, medical, and surgical treatments, although expectant management alone is often highly successful.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref><xref ref-type="bibr" rid="article-17039.r7">[7]</xref><xref ref-type="bibr" rid="article-17039.r8">[8]</xref> Complications, such as sepsis from retained POC, hemorrhagic shock, or cervical shock, are rare but can be severe. The prognosis for these patients is generally good, with proper diagnosis, close obstetric follow-up, and patient education.</p>
      </sec>
      <sec id="article-17039.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>A specific cause for incomplete expulsion of POC is unclear; however, it may potentially occur following any spontaneous miscarriage or induced abortion.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref><xref ref-type="bibr" rid="article-17039.r7">[7]</xref>&#x000a0;Historically, all miscarriages were considered incomplete until uterine curettage confirmed complete expulsion of POC.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref></p>
        <p>Various potential etiologies may result in spontaneous asymptomatic, incomplete, or complete miscarriage. Early pregnancy loss is due to embryonic chromosomal abnormalities in about 50% of cases.<xref ref-type="bibr" rid="article-17039.r9">[9]</xref>&#x000a0;Other risk factors&#x000a0;include maternal age, maternal comorbidities, especially diabetes, hypertension, renal disease, thyroid disorders, celiac disease, systemic lupus erythematosus (SLE), antiphospholipid syndrome, extremes of weight, structural uterine abnormalities, teratogen exposure (eg, drugs, alcohol, or radiation), some infections (eg, parvovirus B19, syphilis, or&#x000a0;<italic toggle="yes">Listeria monocytogenes</italic>), and trauma.<xref ref-type="bibr" rid="article-17039.r10">[10]</xref><xref ref-type="bibr" rid="article-17039.r11">[11]</xref><xref ref-type="bibr" rid="article-17039.r12">[12]</xref><xref ref-type="bibr" rid="article-17039.r13">[13]</xref>&#x000a0;Congenital anomalies and genetic syndromes can also result in miscarriage.&#x000a0;</p>
        <p>It is also possible for an induced abortion to result in incomplete passage of POC, similar to a spontaneous incomplete miscarriage.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref>&#x000a0;Unsafe abortion&#x000a0;may increase the risk of incomplete abortion.<xref ref-type="bibr" rid="article-17039.r14">[14]</xref>&#x000a0;Unsafe abortion is defined&#x000a0;by the World Health Organization (WHO) as an abortion performed by people lacking the necessary skills&#x000a0;or in an environment lacking the minimum medical standards, or both; other definitions also include the use of hazardous techniques, such as ingesting toxic substances, abdominal trauma, and intrauterine instrumentation.<xref ref-type="bibr" rid="article-17039.r15">[15]</xref><xref ref-type="bibr" rid="article-17039.r16">[16]</xref></p>
      </sec>
      <sec id="article-17039.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>By definition, incomplete pregnancy loss occurs in women with a gestational age of &#x0003c;20 weeks. When all subtypes of miscarriage&#x000a0;are considered together, miscarriage&#x000a0;occurs in an estimated 10% to 15% of clinically recognized pregnancies;&#x000a0;the specific incidence of incomplete miscarriage has not been well documented.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref>&#x000a0;In one study, 34% of anembryonic gestations had incomplete expulsion of POC after 1 month, and 26% of pregnancies with embryonic demise managed expectantly did not have complete expulsion of POC after 1 month.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
      </sec>
      <sec id="article-17039.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical History</bold>
</p>
        <p>A thorough history should be obtained that includes medical conditions and obstetric and gynecologic history (eg, previous miscarriages, known uterine anomalies, and the first day of the last menstrual period [LMP]) to identify risk factors and patient-specific issues that may affect management.<xref ref-type="bibr" rid="article-17039.r7">[7]</xref> Clinicians should review any previous ultrasounds from the current gestation and compare them with the calculated estimated due date (EDD) from a sure LMP to determine an accurate estimated gestational age, which can influence the preferred treatment modality.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
        <p>Additionally, clinicians should inquire about presenting symptoms such as cramping and pelvic pain and the quality and quantity of vaginal bleeding noted, including onset, number of saturated pads or tampons per hour, and the number and size of clots present.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;Clinical features characteristic of incomplete pregnancy loss include the passage of clots or tissue, though it is certainly possible for patients to either be unaware of tissue expulsion that has occurred or mistake blood clot for tissue. Bleeding with an incomplete miscarriage is often prolonged and heavier than typical menses; heavy bleeding is frequently defined as soaking 1 to 2 menstrual pads per hour for 2 hours.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;Reports of minimal bleeding and identified tissue following a medical or surgical abortion may also indicate an incomplete abortion.<xref ref-type="bibr" rid="article-17039.r7">[7]</xref>&#x000a0;Similarly, pain or discomfort should be characterized as this often varies with each individual. With an incomplete pregnancy loss, the pain is often described as severe menstrual cramping that is not resolving.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;Patient anxiety can also increase the amount of pain experienced.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
        <p>
<bold>Physical Examination&#x000a0;</bold>
</p>
        <p>An initial assessment of the patient's hemodynamic stability should include vital signs and a focused physical examination. Findings of hypovolemia (eg, tachycardia and hypotension) are suggestive of hemorrhage secondary to heavy uterine bleeding.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;A fever is concerning for infection and possible septic miscarriage, which requires emergent obstetrical consultation and surgical intervention.<xref ref-type="bibr" rid="article-17039.r7">[7]</xref><xref ref-type="bibr" rid="article-17039.r17">[17]</xref></p>
        <p>On pelvic examination, typical findings of an incomplete pregnancy loss include an open cervical os with POC visible within the vaginal vault or protruding from the cervix.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;The presence of purulent vaginal discharge and uterine tenderness strongly suggests infection. The vagina and vulva should also be carefully examined to rule out any nonobstetric causes of bleeding, such as vaginal trauma or bleeding polyps.<xref ref-type="bibr" rid="article-17039.r7">[7]</xref><xref ref-type="bibr" rid="article-17039.r2">[2]</xref><xref ref-type="bibr" rid="article-17039.r7">[7]</xref></p>
        <p>The abdominal exam is typically benign; however, if peritoneal signs are present (eg, rebound tenderness, guarding, and rigidity), obstetrical or general surgery specialists should be consulted, and further evaluation should be emergently performed.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
      </sec>
      <sec id="article-17039.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnostic Imaging&#x000a0;</bold>
</p>
        <p>Early pregnancy is best visualized using transvaginal ultrasound; therefore, this modality is preferred when evaluating a suspected pregnancy loss.<xref ref-type="bibr" rid="article-17039.r18">[18]</xref>&#x000a0;</p>
        <p>An incomplete pregnancy loss can be confirmed by a transvaginal ultrasound demonstrating the partial expulsion of POC and heterogeneous or echogenic contents within the endometrial cavity or endocervical canal in patients with an open cervical os, particularly if an intrauterine pregnancy was previously diagnosed by ultrasound imaging.<xref ref-type="bibr" rid="article-17039.r19">[19]</xref><xref ref-type="bibr" rid="article-17039.r18">[18]</xref><xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;Additional findings on transvaginal ultrasound consistent with retained POC include a mass or focal thickening within the endometrium; occasionally, blood flow can be visualized within this area using Doppler imaging.<xref ref-type="bibr" rid="article-17039.r18">[18]</xref>&#x000a0;A nonviable pregnancy noted on imaging with persistent&#x000a0;&#x003b2;-human chorionic gonadotropin (&#x003b2;-hCG) levels also suggests an incomplete pregnancy loss.<xref ref-type="bibr" rid="article-17039.r18">[18]</xref></p>
        <p>If no previous imaging studies have established a viable intrauterine pregnancy for comparison, a nonviable pregnancy can be diagnosed with 100% specificity with a single transvaginal ultrasound demonstrating an intrauterine fetal crown-to-rump length of &#x0003e;7 mm without fetal heart tones or if no embryo is noted within a gestational sac with an average diameter of &#x0003e;25 mm.<xref ref-type="bibr" rid="article-17039.r17">[17]</xref>&#x000a0;&#x000a0;There is no consensus on transvaginal ultrasound findings indicative of a completed miscarriage; however, the absence of a gestational sac and an endometrial thickness of &#x0003c;30 mm is often used in studies.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref></p>
        <p>
<bold>Diagnostic Laboratory Studies</bold>
</p>
        <p>The following laboratory studies should be performed to assist in patient management decisions.</p>
        <p><bold>&#x003b2;-hCG</bold>: The diagnosis of incomplete pregnancy loss is primarily based on clinical assessment and pelvic ultrasound; however, quantitative serum &#x003b2;-human chorionic gonadotropin (&#x003b2;-hCG) levels may be helpful in the diagnostic evaluation of patients without an accurate gestational age due to an unsure LMP or that are found to have a pregnancy of unknown location.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref><xref ref-type="bibr" rid="article-17039.r20">[20]</xref>&#x000a0;</p>
        <p>An intrauterine pregnancy typically can be expected to be visible on ultrasound at around 5 to 6 weeks of gestation. However, if the gestational age of a pregnancy is uncertain, a &#x003b2;-hCG level can help a clinician interpret pelvic ultrasound findings.<xref ref-type="bibr" rid="article-17039.r20">[20]</xref>&#x000a0;Traditionally, a &#x003b2;-hCG level of 1,000 to 2,000 mIU/mL was used as the "discriminatory zone"&#x000a0;at which an intrauterine pregnancy could be visualized by transvaginal ultrasound; if not seen, either ectopic pregnancy or early pregnancy loss was likely. Recently, some studies have recommended that a &#x003b2;-hCG level of &#x0003e;3,500 mIU/mL would be more appropriate as normal intrauterine pregnancies are still possible below that level.<xref ref-type="bibr" rid="article-17039.r20">[20]</xref></p>
        <p>A pregnancy of unknown location refers to a pregnant patient in whom a pelvic ultrasound study does not definitively demonstrate an intrauterine or ectopic pregnancy. In stable patients,&#x000a0;&#x003b2;-hCG levels, which&#x000a0;increase at a predictable rate in early pregnancy until plateauing at around 10 weeks of gestation, should be followed over several days to observe the trend. A slow increase or&#x000a0;decrease in the &#x003b2;-hCG level before its plateau can indicate a&#x000a0;failing or abnormal pregnancy.<xref ref-type="bibr" rid="article-17039.r21">[21]</xref><xref ref-type="bibr" rid="article-17039.r20">[20]</xref>&#x000a0;It should be noted that ectopic pregnancies may have &#x003b2;-hCG levels that decrease before increasing again, and they can rupture even while &#x003b2;-hCG levels are decreasing.&#x000a0;</p>
        <p>A &#x003b2;-hCG level is not diagnostic in itself and should&#x000a0;<italic toggle="yes">always</italic> be interpreted with caution within the larger clinical context to avoid misdiagnosis; whenever the diagnosis of a hemodynamically stable patient is unclear, repeating ultrasound imaging and serial &#x003b2;-hCG levels, typically every 48 hours, are indicated.<xref ref-type="bibr" rid="article-17039.r18">[18]</xref><xref ref-type="bibr" rid="article-17039.r20">[20]</xref></p>
        <p><bold>Hemoglobin and hematocrit</bold>: Due to the heavy amount of bleeding typical in most symptomatic patients, assessment for acute blood loss anemia should be performed at the initial presentation.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
        <p><bold>Blood type with Rh(D) status</bold>: A&#x000a0;possible transfusion may need to be performed, or Rh(D)-immune globulin administered in Rh(D)-negative patients; therefore, blood typing and Rh(D) status should be obtained with initial laboratory studies.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
        <p><bold>Pathology studies</bold>: Any pregnancy tissue removed from the vagina vault or expelled should be sent for histological examination to confirm pregnancy loss and assess for a molar pregnancy.<xref ref-type="bibr" rid="article-17039.r17">[17]</xref></p>
        <p><bold>Sepsis laboratory studies</bold>: For patients where a septic incomplete miscarriage or abortion is suspected, additional laboratory evaluation is indicated, including complete blood count with a differential, comprehensive metabolic panel, serum lactate, blood and urine cultures, and endocervical cultures.<xref ref-type="bibr" rid="article-17039.r22">[22]</xref></p>
      </sec>
      <sec id="article-17039.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Approach to Management&#x000a0;</bold>
</p>
        <p>Early pregnancy loss can generally be managed with expectant, medical, or surgical approaches.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref>&#x000a0;Although clinicians traditionally used surgical management in most patients with incomplete pregnancy loss, current US guidelines from the American College of Obstetricians and Gynecologists (ACOG)&#x000a0;state that patients with early pregnancy loss can be offered all three approaches (ie, expectant, medical, and surgical) as first-line options and that patient preference should guide management.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;On the other hand, some guidelines, including those from the National Institutes of Health and Care Excellence (NICE) in the UK, more explicitly prefer 1 to 2 weeks of expectant management&#x000a0;as the first-line approach in patients without contraindications. However, NICE guidelines note that medical management should be offered if the patient declines expectant management.<xref ref-type="bibr" rid="article-17039.r23">[23]</xref>&#x000a0;In patients with incomplete pregnancy loss, limited evidence suggests that medical management may not be any more beneficial than expectant management. Depending on clinical and patient factors, any of these approaches can be appropriate.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref>&#x000a0;</p>
        <p>
<bold>Expectant and Medical Management</bold>
</p>
        <p>Expectant management consists of the watchful monitoring of patients without contraindications to this approach, allowing the natural process of miscarriage to progress spontaneously if the patient remains stable and shows no evidence of infection.&#x000a0;It has a high success rate in patients with first-trimester incomplete miscarriage, with up to 53% of patients having complete expulsion of POC within 1 week without additional medical or surgical treatment, compared to 30% of asymptomatic patients with embryonic demise.<xref ref-type="bibr" rid="article-17039.r19">[19]</xref>&#x000a0;&#x000a0;A Cochrane review found that expectant and medical management were equally effective.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref> However, with an expectant approach, it may take longer for POC to be expelled. Other methods should be offered when the patient decides not to continue expectant management.<xref ref-type="bibr" rid="article-17039.r19">[19]</xref> Therefore, ACOG states that "there is insufficient evidence to support or refute the use of misoprostol among women with incomplete pregnancy loss."<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;</p>
        <p>If medical management is selected, ACOG recommends vaginal misoprostol 800 mcg once initially, with a potential second dose between 3 hours and 7 days later.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref> The World Health Organization prefers misoprostol regimens of 400 mcg sublingually once or 600 mcg orally only once for pregnancies &#x0003c;14 weeks of gestation.<xref ref-type="bibr" rid="article-17039.r7">[7]</xref>&#x000a0;One large study of women with incomplete abortion showed that the rate of complete abortion within 14 to 28 days of initial treatment with&#x000a0;misoprostol without surgical intervention was 96.2%.<xref ref-type="bibr" rid="article-17039.r24">[24]</xref></p>
        <p>With either approach, patients should be counseled to expect heavy bleeding and cramping, often greater than what is experienced with typical menses.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;Symptoms tend to improve after the POC have been expelled, though some scant to moderate bleeding may last for several weeks.&#x000a0;All&#x000a0;patients should be instructed to seek medical care if they are soaking 2 pads per hour for &#x02264;2 consecutive hours or if they develop dizziness, lightheadedness, or a fever.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref></p>
        <p>Appropriate analgesics should also be offered. Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen or paracetamol are typically considered first-line agents, though some patients may require additional medications for a short time. Unless there is an infection, antibiotics are not indicated.</p>
        <p>Patients should also have a follow-up&#x000a0;plan to ensure the safe completion of the miscarriage. NICE guidelines recommend instructing the patient to take a home urine pregnancy test 3 weeks after bleeding and pain resolve and to return for evaluation if it is positive or if symptoms do not resolve after 2 weeks of expectant management. ACOG states a scheduled follow-up appointment with a repeat ultrasound to ensure complete expulsion of the gestational sac or serial serum &#x003b2;-hCG measurements in areas where ultrasound is unavailable should be performed.&#x000a0;Patients with persistent POC, despite expectant or medical management, should be offered surgical management.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref><xref ref-type="bibr" rid="article-17039.r23">[23]</xref></p>
        <p>
<bold>Surgical Management</bold>
</p>
        <p>Surgical management for incomplete pregnancy loss is indicated in patients with hemodynamic instability, those at high risk for hemorrhage&#x000a0;or with septic miscarriages, and people who failed expectant or medical management.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref>&#x000a0;Additionally, surgical management is also preferred in&#x000a0;those who cannot tolerate large drops in hemoglobin (eg, severe anemia, certain cardiovascular diseases). Results from a randomized controlled trial of 652 women with early pregnancy failure showed that when compared to surgical management, medical management was associated with heavier and more prolonged bleeding and a higher risk of a drop in hemoglobin &#x0003e;2 g/dL.<xref ref-type="bibr" rid="article-17039.r25">[25]</xref>&#x000a0;Surgical management is typically considered "definitive treatment" and, if selected,&#x000a0;can be accomplished via uterine aspiration or suction curettage in either an operating room or, if clinically appropriate, an outpatient setting under local anesthesia. A dose of prophylactic antibiotics,&#x000a0;doxycycline 200 mg intravenously once 1 hour before the procedure, is typically recommended.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref></p>
        <p>
<bold>Rh(D)-immune Globulin</bold>
</p>
        <p>Rh(D)-immune globulin can be given to Rh-negative patients to prevent alloimmunization. Its use is consistently recommended after surgical management&#x000a0;but is more controversial with expectant or medical management of pregnancy loss in the first trimester.&#x000a0;</p>
        <p>ACOG states, "Although the risk of alloimmunization is low, the consequences can be significant, and administration of Rh(D)-immune globulin should be considered in cases of early pregnancy loss, especially those later in the first trimester."<xref ref-type="bibr" rid="article-17039.r25">[25]</xref>&#x000a0;In many places throughout the US, universal prophylaxis is standard, even in the first trimester. In the UK, NICE guidelines explicitly recommend&#x000a0;<italic toggle="yes">against&#x000a0;</italic>its use after expectant or medical management of miscarriage before 12 weeks of gestation.<xref ref-type="bibr" rid="article-17039.r23">[23]</xref> Conversely, the British Committee for Standards in Haematology (BCSH), supported by the Royal College of Obstetricians and Gynaecologists (RCOG), does consider its use appropriate before 12 weeks when uterine bleeding is "repeated, heavy, or associated with abdominal pain," which would be the case in almost all patients with incomplete miscarriage.<xref ref-type="bibr" rid="article-17039.r26">[26]</xref>&#x000a0;Given these varying recommendations, regional and institutional protocols should guide management, if available.</p>
        <p>A dose of Rh(D)-immune globulin 50 to 120 mcg intramuscularly once in the first trimester is typically recommended. After 12 weeks of gestation,&#x000a0;ACOG guidelines recommend a dose of 300 mcg intramuscularly once, though the guidelines of some other countries recommend lower doses depending on the situation.<xref ref-type="bibr" rid="article-17039.r27">[27]</xref><xref ref-type="bibr" rid="article-17039.r26">[26]</xref></p>
      </sec>
      <sec id="article-17039.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In addition to incomplete miscarriage, the differential diagnosis for vaginal bleeding in pregnancy includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ectopic pregnancy</p>
          </list-item>
          <list-item>
            <p>Complete miscarriage</p>
          </list-item>
          <list-item>
            <p>Threatened miscarriage</p>
          </list-item>
          <list-item>
            <p>Subchorionic hemorrhage or hematoma</p>
          </list-item>
          <list-item>
            <p>Molar pregnancy</p>
          </list-item>
          <list-item>
            <p>Nonobstetric bleeding (eg, vaginal or cervical trauma, malignancy, or polyps)</p>
          </list-item>
          <list-item>
            <p>Infection of the vagina or cervix (eg, candidiasis, bacterial vaginosis, and <italic toggle="yes">C</italic><italic toggle="yes">hlamydia trachomatis</italic>)<xref ref-type="bibr" rid="article-17039.r28">[28]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Septic abortion</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic shock</p>
          </list-item>
          <list-item>
            <p>Cervical shock</p>
          </list-item>
          <list-item>
            <p>Uterine rupture<xref ref-type="bibr" rid="article-17039.r29">[29]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17039.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with incomplete pregnancy loss typically have a very good prognosis&#x000a0;with expectant management; approximately 90% of patients have complete expulsion of POC within 4 weeks.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;The prognosis&#x000a0;with medical management is similar.<xref ref-type="bibr" rid="article-17039.r5">[5]</xref>&#x000a0;Surgical management is considered "definitive treatment," and similar to expectant and medical management, the prognosis is also excellent. Future fertility does not appear to be impacted. It is safe to attempt conception immediately following a miscarriage. Studies have shown that live birth rates are higher for conceptions occurring within the first 3 months following a pregnancy loss than those who postpone conception.<xref ref-type="bibr" rid="article-17039.r30">[30]</xref><xref ref-type="bibr" rid="article-17039.r31">[31]</xref></p>
      </sec>
      <sec id="article-17039.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The risk of complications appears similar across management strategies.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref> The primary complications of incomplete pregnancy loss in the first trimester include retained POC, hemorrhage potentially requiring a blood transfusion, disseminated intravascular coagulation, endometritis, and sepsis.<xref ref-type="bibr" rid="article-17039.r17">[17]</xref> The risk of infection appears higher in low-income compared to high-income countries. If an infection develops, the provider should consider the possibility of a polymicrobial infection of retained POC, typically due to genital flora.<xref ref-type="bibr" rid="article-17039.r32">[32]</xref> The risk of death, while possible, is negligible for uncomplicated miscarriages before 12 weeks.&#x000a0;</p>
        <p>Patients may experience some adverse reactions to medical management, most commonly nausea, vomiting, and diarrhea.<xref ref-type="bibr" rid="article-17039.r33">[33]</xref> Surgical management may be complicated by uterine perforation and anesthesia reactions. Limited evidence also suggests that surgical management may increase the risk of intrauterine adhesions, though this is more likely after sharp curettage or repeated procedures.<xref ref-type="bibr" rid="article-17039.r34">[34]</xref>&#x000a0;The risk of complications is also&#x000a0;generally higher with second-trimester losses, including risks for hemorrhage, infection, cervical laceration, and pulmonary embolism with medical and surgical approaches to management. Although rare, uterine rupture has also been reported with medical management of losses in the second trimester.<xref ref-type="bibr" rid="article-17039.r6">[6]</xref></p>
        <p>One rare complication unique to incomplete miscarriage is cervical shock. With cervical shock, POC within the cervical canal can lead to excessive vagal stimulation, resulting in bradycardia and hypotension that does not respond to IV fluids.<xref ref-type="bibr" rid="article-17039.r35">[35]</xref>&#x000a0;In this situation, the POC should be immediately removed from the cervix, which can usually be accomplished easily using ring forceps or a similar type of instrument during a speculum exam; transfer to the operating suite and sedation are not necessary in most cases and may instead delay this definitive treatment.<xref ref-type="bibr" rid="article-17039.r35">[35]</xref></p>
      </sec>
      <sec id="article-17039.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>A patient who presents to an emergency department with unstable vital signs and heavy bleeding will need emergent obstetric evaluation and possible intervention. Stable patients require follow-up with obstetric clinicians to confirm the completion of the miscarriage and to receive family planning counseling (eg, contraceptive or preconception counseling). Patients with recurrent pregnancy loss can be referred to a reproductive endocrinology and infertility (REI) specialist. Patients may also be referred to mental health or other emotional support services, as feelings of grief, guilt, and depression are common following pregnancy loss; however, this should be done individually as there has not been definitive evidence of improvement in patient outcomes.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref></p>
      </sec>
      <sec id="article-17039.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should not delay seeking medical care if they experience bleeding during pregnancy, as this can lead to increased morbidity and mortality.<xref ref-type="bibr" rid="article-17039.r36">[36]</xref>&#x000a0;After a woman is evaluated by a healthcare professional and diagnosed with incomplete pregnancy loss, patients should be counseled on the risks and benefits of each management approach; joint decision-making between the patient and provider can then be used to select a treatment modality.<xref ref-type="bibr" rid="article-17039.r4">[4]</xref></p>
        <p>Following treatment, patients should be counseled to expect to continue bleeding for 1 to 2 weeks, sometimes longer, particularly with expectant management. Clinicians should also provide patients precautions, instructing them to return for evaluation if bleeding is heavy enough to soak through 1 to 2 pads per hour for 2 consecutive hours, if the pain is uncontrolled by over-the-counter analgesics, or if a fever develops. Patients should also be scheduled for follow-up to confirm the complete expulsion of POC from the uterus. Typically this is done with a&#x000a0;pelvic ultrasound; however, a decrease in &#x003b2;-hCG levels by 50% after 2&#x000a0; days or 87% by 7 days may also be used if ultrasound is unavailable.<xref ref-type="bibr" rid="article-17039.r2">[2]</xref>&#x000a0;&#x000a0;Patients can also be reassured that uncomplicated pregnancy loss does not impact future fertility. Additionally, ovulation often resumes within the first cycle&#x000a0;after the expulsion of fetal tissues, so patients should be offered contraception if they do not desire another pregnancy right away.<xref ref-type="bibr" rid="article-17039.r37">[37]</xref></p>
      </sec>
      <sec id="article-17039.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>An incomplete miscarriage is primarily diagnosed when POC are visible within the cervical canal or vaginal vault on examination.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Expectant management is highly effective in these patients. It is unclear if medical management adds any benefit, but it can be offered if the patient desires.</p>
          </list-item>
          <list-item>
            <p>Surgical management is indicated in patients with hemodynamic instability, signs of infection, patients who cannot tolerate a significant drop in hemoglobin, and those who have failed expectant or medical management. According to some guidelines, including those from the US, surgical management is also appropriate as a first-line treatment option if the patient desires.</p>
          </list-item>
          <list-item>
            <p>Patients with pregnancy loss&#x000a0;tend to have better mental health outcomes if they&#x000a0;can choose&#x000a0;their&#x000a0;treatment plans. Women who were&#x000a0;managed according&#x000a0;to&#x000a0;their&#x000a0;preference (ie, expectant, medical, or surgical management) had better mental health outcomes than their cohorts who were&#x000a0;randomized&#x000a0;to&#x000a0;either&#x000a0;expectant&#x000a0;or&#x000a0;surgical&#x000a0;management&#x000a0;after&#x000a0;12 weeks.<xref ref-type="bibr" rid="article-17039.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>A patient presenting with vaginal bleeding in early pregnancy, hypotension, and&#x000a0;bradycardia may have cervical shock from vagal stimulation secondary to the persistent presence of POC in the endocervical canal. Symptoms can improve rapidly by removing the POC from the cervical canal with ring forceps or a similar instrument on a bedside speculum exam.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17039.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of patients with incomplete pregnancy loss can involve a wide range of healthcare professionals across multiple disciplines, including physicians (eg, obstetricians, emergency medicine and family medicine physicians, and radiologists), advanced practice nurses, physician assistants, nursing staff, pharmacists, and radiology, laboratory, and pharmacy technicians. Management consultation between emergency, radiology, and obstetric clinicians, patient counseling and provision of prescriptions, and coordination of follow-up care all require interprofessional communication and cooperation. Patients may also struggle with mental health and spiritual concerns related to pregnancy loss, so mental health professionals, chaplains, and grief counselors may also play an essential role in enhancing patient outcomes.<xref ref-type="bibr" rid="article-17039.r39">[39]</xref>&#x000a0;Clinical and nonclinical staff should be trained to communicate sensitively with women experiencing early pregnancy complications.<xref ref-type="bibr" rid="article-17039.r40">[40]</xref></p>
      </sec>
      <sec id="article-17039.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17039&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17039">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/incomplete-miscarriage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17039">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17039/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17039">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17039.s16">
        <title>References</title>
        <ref id="article-17039.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <article-title>Management of Stillbirth: Obstetric Care Consensus No, 10.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>e110</fpage>
            <page-range>e110-e132</page-range>
            <pub-id pub-id-type="pmid">32080052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendriks</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>First Trimester Bleeding: Evaluation and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-174</page-range>
            <pub-id pub-id-type="pmid">30702252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolte</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Quenby</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farquharson</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Goddijn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>MD</given-names>
              </name>
              <collab>ESHRE Special Interest Group, Early Pregnancy</collab>
            </person-group>
            <article-title>Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group.</article-title>
            <source>Hum Reprod</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>495</fpage>
            <page-range>495-8</page-range>
            <pub-id pub-id-type="pmid">25376455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 200: Early Pregnancy Loss.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>e197</fpage>
            <page-range>e197-e207</page-range>
            <pub-id pub-id-type="pmid">30157093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hickey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Dou</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Medical treatments for incomplete miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <day>31</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD007223</fpage>
            <pub-id pub-id-type="pmid">28138973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <article-title>ACOG Practice Bulletin No. 135: Second-trimester abortion.</article-title>
            <source>Obstet Gynecol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>121</volume>
            <issue>6</issue>
            <fpage>1394</fpage>
            <page-range>1394-1406</page-range>
            <pub-id pub-id-type="pmid">23812485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r7">
          <label>7</label>
          <element-citation publication-type="book">
            <source>Abortion care guideline [Internet]</source>
            <publisher-name>World Health Organization</publisher-name>
            <publisher-loc>Geneva</publisher-loc>
            <year>2022</year>
            <pub-id pub-id-type="pmid">35344310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <source>Medical management of abortion</source>
            <publisher-name>World Health Organization</publisher-name>
            <publisher-loc>Geneva</publisher-loc>
            <year>2018</year>
            <pub-id pub-id-type="pmid">30702834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sigurjonsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pettersen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maisenbacher</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Demko</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lathi</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rabinowitz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>124</volume>
            <issue>2 Pt 1</issue>
            <fpage>202</fpage>
            <page-range>202-209</page-range>
            <pub-id pub-id-type="pmid">25004334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine</collab>
            <article-title>Evaluation and treatment of recurrent pregnancy loss: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>1103</fpage>
            <page-range>1103-11</page-range>
            <pub-id pub-id-type="pmid">22835448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metwally</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Ledger</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence.</article-title>
            <source>Fertil Steril</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>714</fpage>
            <page-range>714-26</page-range>
            <pub-id pub-id-type="pmid">18068166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maraka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>O'Keeffe</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Espinosa De Ycaza</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Gionfriddo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Coddington</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>580</fpage>
            <page-range>580-90</page-range>
            <pub-id pub-id-type="pmid">26837268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiong</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.</article-title>
            <source>J Clin Virol</source>
            <year>2019</year>
            <month>May</month>
            <volume>114</volume>
            <fpage>12</fpage>
            <page-range>12-20</page-range>
            <pub-id pub-id-type="pmid">30897374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Othieno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Babigumira</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Are women with complications of an incomplete abortion more likely to be HIV infected than women without complications?</article-title>
            <source>BMC Womens Health</source>
            <year>2015</year>
            <month>Oct</month>
            <day>26</day>
            <volume>15</volume>
            <fpage>95</fpage>
            <pub-id pub-id-type="pmid">26503499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganatra</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tun&#x000e7;alp</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>G&#x000fc;lmezoglu</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Temmerman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>From concept to measurement: operationalizing WHO's definition of unsafe abortion.</article-title>
            <source>Bull World Health Organ</source>
            <year>2014</year>
            <month>Mar</month>
            <day>01</day>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <pub-id pub-id-type="pmid">24700971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fawcus</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Maternal mortality and unsafe abortion.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>533</fpage>
            <page-range>533-48</page-range>
            <pub-id pub-id-type="pmid">18249585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinley</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prager</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Nagdev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Manual Uterine Aspiration: Adding to the Emergency Physician Stabilization Toolkit.</article-title>
            <source>Ann Emerg Med</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-92</page-range>
            <pub-id pub-id-type="pmid">29248332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Women&#x02019;s Imaging:</collab>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Packard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maturen</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dudiak</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Henrichsen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Poder</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sadowski</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Shipp</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Zelop</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Glanc</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> First Trimester Vaginal Bleeding.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5S</issue>
            <fpage>S69</fpage>
            <page-range>S69-S77</page-range>
            <pub-id pub-id-type="pmid">29724428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prine</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Office management of early pregnancy loss.</article-title>
            <source>Am Fam Physician</source>
            <year>2011</year>
            <month>Jul</month>
            <day>01</day>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-82</page-range>
            <pub-id pub-id-type="pmid">21766758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>e91</fpage>
            <page-range>e91-e103</page-range>
            <pub-id pub-id-type="pmid">29470343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cary</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Morse</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takacs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Senapati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sammel</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>504</fpage>
            <page-range>504-511</page-range>
            <pub-id pub-id-type="pmid">27500326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udoh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Effa</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Oduwole</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Okusanya</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Okafo</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics for treating septic abortion.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>CD011528</fpage>
            <pub-id pub-id-type="pmid">27364644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rafi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Expectant management of miscarriage in view of NICE Guideline 154.</article-title>
            <source>J Pregnancy</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>824527</fpage>
            <pub-id pub-id-type="pmid">24868466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klingberg-Allvin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cleeve</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Atuhairwe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tumwesigye</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Faxelid</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Byamugisha</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gemzell-Danielsson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial.</article-title>
            <source>Lancet</source>
            <year>2015</year>
            <month>Jun</month>
            <day>13</day>
            <volume>385</volume>
            <issue>9985</issue>
            <fpage>2392</fpage>
            <page-range>2392-8</page-range>
            <pub-id pub-id-type="pmid">25817472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Hendlish</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
              <collab>National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial</collab>
            </person-group>
            <article-title>Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>196</volume>
            <issue>1</issue>
            <fpage>31.e1</fpage>
            <page-range>31.e1-7</page-range>
            <pub-id pub-id-type="pmid">17240222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qureshi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kirwan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Allard</surname>
                <given-names>S</given-names>
              </name>
              <collab>British Society for Haematology</collab>
            </person-group>
            <article-title>BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.</article-title>
            <source>Transfus Med</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-20</page-range>
            <pub-id pub-id-type="pmid">25121158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e57</fpage>
            <page-range>e57-e70</page-range>
            <pub-id pub-id-type="pmid">28742673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griebel</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Halvorsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Golemon</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Management of spontaneous abortion.</article-title>
            <source>Am Fam Physician</source>
            <year>2005</year>
            <month>Oct</month>
            <day>01</day>
            <volume>72</volume>
            <issue>7</issue>
            <fpage>1243</fpage>
            <page-range>1243-50</page-range>
            <pub-id pub-id-type="pmid">16225027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birch</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mandalia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cervical shock: a complication of incomplete abortion.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28710197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sundermann</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Torstenson</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Velez Edwards</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Interpregnancy Interval After Pregnancy Loss and Risk of Repeat Miscarriage.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>130</volume>
            <issue>6</issue>
            <fpage>1312</fpage>
            <page-range>1312-1318</page-range>
            <pub-id pub-id-type="pmid">29112656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schliep</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Mumford</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Radin</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Zarek</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Sjaarda</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schisterman</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-12</page-range>
            <pub-id pub-id-type="pmid">26942344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouse</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Eckert</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Stringer</surname>
                <given-names>JSA</given-names>
              </name>
              <name>
                <surname>Kochhar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanicas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dudley</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Bittaye</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jehan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maltezou</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>&#x00160;ubelj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bardaji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kachikis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beigi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gravett</surname>
                <given-names>MG</given-names>
              </name>
              <collab>Global Alignment of Immunization Safety in Pregnancy (GAIA) Postpartum Endometritis, Infection following Incomplete or Complete Abortion Work Group</collab>
            </person-group>
            <article-title>Postpartum endometritis and infection following incomplete or complete abortion: Case definition &#x00026; guidelines for data collection, analysis, and presentation of maternal immunization safety data.</article-title>
            <source>Vaccine</source>
            <year>2019</year>
            <month>Dec</month>
            <day>10</day>
            <volume>37</volume>
            <issue>52</issue>
            <fpage>7585</fpage>
            <page-range>7585-7595</page-range>
            <pub-id pub-id-type="pmid">31783980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>MM</given-names>
              </name>
              <collab>National Institute of Child Health Human Development (NICHD) Management of Early Pregnancy Failure Trial</collab>
            </person-group>
            <article-title>A comparison of medical management with misoprostol and surgical management for early pregnancy failure.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Aug</month>
            <day>25</day>
            <volume>353</volume>
            <issue>8</issue>
            <fpage>761</fpage>
            <page-range>761-9</page-range>
            <pub-id pub-id-type="pmid">16120856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tam</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Intrauterine adhesions after conservative and surgical management of spontaneous abortion.</article-title>
            <source>J Am Assoc Gynecol Laparosc</source>
            <year>2002</year>
            <month>May</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-5</page-range>
            <pub-id pub-id-type="pmid">11960045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyejo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Moshi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kapesi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ntiyakunze</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gidion</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaguta</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cervical vasovagal shock: A rare complication of incomplete abortion case report.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>97</volume>
            <fpage>107455</fpage>
            <pub-id pub-id-type="pmid">35907297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gebretsadik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Factors Associated with Management Outcome of Incomplete Abortion in Yirgalem General Hospital, Sidama Zone, Southern Ethiopia.</article-title>
            <source>Obstet Gynecol Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>3958681</fpage>
            <pub-id pub-id-type="pmid">30327673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gemzell-Danielsson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kopp Kallner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fa&#x000fa;ndes</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Contraception following abortion and the treatment of incomplete abortion.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>126 Suppl 1</volume>
            <fpage>S52</fpage>
            <page-range>S52-5</page-range>
            <pub-id pub-id-type="pmid">24739476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wieringa-De Waard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hartman</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Ankum</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Bindels</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Bonsel</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Expectant management versus surgical evacuation in first trimester miscarriage: health-related quality of life in randomized and non-randomized patients.</article-title>
            <source>Hum Reprod</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>1638</fpage>
            <page-range>1638-42</page-range>
            <pub-id pub-id-type="pmid">12042291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kong</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Lok</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Yiu</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial.</article-title>
            <source>Aust N Z J Obstet Gynaecol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>170</fpage>
            <page-range>170-7</page-range>
            <pub-id pub-id-type="pmid">23488984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17039.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <source>Ectopic pregnancy and miscarriage: diagnosis and initial management</source>
            <publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>
            <publisher-loc>London</publisher-loc>
            <year>2023</year>
            <month>08</month>
            <day>23</day>
            <pub-id pub-id-type="pmid">31393678</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
